about
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnosti...
Read More
18.35
-0.27
(-1.45%)
706.7K
XNAS Volume
XNAS 06 Aug, 2026 11:44 AM (EDT)
Board Meeting
The next board meeting for Erasca Inc is on 12 Aug 2026 for the purpose of Erasca Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Erasca Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..